M. Ligumsky
Impact in
- Pharmacology top 0.1%
- Cannabis and Cannabinoid Research
- Inflammatory mediators and NSAID effects
- Toxicology top 0.5%
Papers in
-
- Gastroesophageal reflux and treatments 5
- Gastrointestinal motility and disorders 4
- Pharmacology 24
- Inflammatory mediators and NSAID effects 23
- Co-authors
- Daniel RachmilewitzU. ZorP. SharonFanny KarmeliAsher GopherShimon Ben‐ShabatRaphael MechoulamShlomo Almog
- Journals
- Gastroenterology (9 papers)Scandinavian Journal of Gastroenterology (6 papers)Gut (4 papers)Digestion (3 papers)Inflammation Research (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
M. Ligumsky
68 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmacology 3.0k
- Toxicology 277
- Gastroenterology 356
- Cellular and Molecular Neuroscience 1.2k
- Endocrine and Autonomic Systems 318
Countries citing papers authored by M. Ligumsky
This map shows the geographic impact of M. Ligumsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ligumsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ligumsky more than expected).
Fields of papers citing papers by M. Ligumsky
This network shows the impact of papers produced by M. Ligumsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ligumsky. The network helps show where M. Ligumsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Ligumsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 37 | |
| 2 | 2003 | 34 | |
| 3 | 2002 | 52 | |
| 4 | 2001 | 49 | |
| 5 | 2000 | 15 | |
| 6 | 1997 | 13 | |
| 7 | 1996 | 17 | |
| 8 | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Hit paper breakdown → | 1995 | 2291 |
| 9 | 1994 | 22 | |
| 10 | 1990 | 337 | |
| 11 | 1990 | 19 | |
| 12 | 1990 | 11 | |
| 13 | 1989 | 11 | |
| 14 | 1989 | 16 | |
| 15 | 1988 | 18 | |
| 16 | 1988 | 18 | |
| 17 | 1988 | 8 | |
| 18 | 1987 | 5 | |
| 19 | 1979 | 4 | |
| 20 | Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Hit paper breakdown → | 1978 | 378 |
About M. Ligumsky
M. Ligumsky is a scholar working on Gastroenterology, Pharmacology, Surgery, Biochemistry and Small Animals, having authored 68 papers that have together received 5.2k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (30 papers), Inflammatory mediators and NSAID effects (23 papers), Inflammatory Bowel Disease (9 papers), Potassium and Related Disorders (8 papers), Gastroesophageal reflux and treatments (5 papers), Gastrointestinal motility and disorders (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Antioxidant Activity and Oxidative Stress (4 papers). The work is most often cited by research in Pharmacology (3.0k citations), Toxicology (277 citations), Gastroenterology (356 citations), Cellular and Molecular Neuroscience (1.2k citations) and Endocrine and Autonomic Systems (318 citations). M. Ligumsky has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Daniel Rachmilewitz, U. Zor, P. Sharon, Fanny Karmeli, Asher Gopher, Shimon Ben‐Shabat, Raphael Mechoulam, Shlomo Almog, Michael Bayewitch and Zvi Vogel. Their work appears in journals such as Gastroenterology, Scandinavian Journal of Gastroenterology, Gut, Digestion and Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.